Advapro Coronary Stent System in Coronary Artery Diseased Patients.

Inclusion Criteria: * Age \>18 years * Gender : All (Males, Females, Transgenders, Non-binary) * ICF : Patient or legally authorized representative (LAR) agrees to participation by signing the informed consent form. * Condition - Clinical : Patient with coronary artery disease Eligible for percutaneous coronary intervention (PCI) * Condition - Angiographic : Patient with coronary artery disease having one or more de novo stenosis lesion in two native coronary artery with a visually estimated diameter stenosis ≥70% * Condition - Angiographic : Patients with Reference vessel diameter of 2.5 \~ 3.50 mm * Condition - Angiographic : Patients with lesion length ≤ 36 mm Exclusion Criteria: * Ethical : Pregnant and lactating females * Patients requiring staged procedure * Condition : Known congestive heart failure (NYHA IV) or left ventricular ejection fraction (LVEF) \<30% * Condition : Patients with known hypersensitivity or allergies to aspirin, heparin, clopidogrel, ticlopidine, Sirolimus or similar drugs, or any other analogue or derivative, cobalt, chromium, nickel, molybdenum or contrast media * Condition : Current medical condition with a life expectancy of less than 12 months * Condition : Diagnosis: Acute Myocardial Infarction within 72 hours of Planned Index procedure * Condition : Patient has current unstable arrhythmias * Procedural : Patients previously treated with PCI or CABG for any coronary artery lesion revascularization * Procedural : Patients with Chronic Tota…